Table 1.
Demographic characteristics of completing participants.
| Medication Group: | Lisinopril (ACE-Inhibitor) n=20 | Atenolol (Beta-blocker) n=23 |
|---|---|---|
| Age | 53.9 (5.6) | 51.3 (7.4) |
| Gender (% male) | 70 | 83 |
| Race (% Caucasian) | 80 | 96 |
| Body Mass Index (kg/m2) | 30.5 (4.9) | 29.5 (4.7) |
| Education (%>high school) | 80 | 96 |
| Married (%) | 55 | 57 |
| Total Cholesterol (mg/dl) | 203 (34) | 214 (31) |
| Glucose (mg/dl) | 98 (20) | 96 (30) |
| Drink alcohol more than 1 or 2 times per year (% of group) | 55 | 48 |
| Average Number of Cigarettes/day | 2 (5) | 1(4) |
| Sulcus size rating | 3.0 (.8) | 2.8 (.9) |
| Ventricle size rating | 2.2 (.6) | 2.2 (1.1) |
| White Matter rating | 1.3 (.8) | 1.2 (.6) |
| Medication Compliance (%) | 97 (8) | 98 (2) |
Arithmetic mean and (standard deviation). Groups compared by independent t-tests or chi-square, no statistically significant differences were observed between medication groups.